Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T07:58:45.976Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Achromobacter xylosoxidans Infections

Published online by Cambridge University Press:  08 April 2017

Paul E. Schoch  and
Burke A. Cunha
Paul E. Schoch
Affiliation:
Department of Pathology and the Infectious Disease Division, Winthrop-University Hospital, Mineola, New York
Burke A. Cunha*
Affiliation:
Department of Pathology and the Infectious Disease Division, Winthrop-University Hospital, Mineola, New York
*
Infectious Disease Division, Winthrop-University Hospital, Mineola, New York 11501
Get access Rights & Permissions [Opens in a new window]

Extract

In 1971, Yabuuchi and Ohyama named and described Achromobacter xylosoxidans as a distinctive gram-negative, nonfermentative bacillus. During the past 15 years, A xylosoxidans has been infrequently reported in the literature as a nosocomial pathogen. The organism has usually been associated with aquatic surroundings and frequently colonizes aqueous fluids in the hospital environment, awaiting the opportunity to infect compromised patients. Several outbreaks have been reported to be caused by Achromobacter, and all have contaminated fluids as the epidemiologic “common denominator.” Achromobacter is an emerging pathogen that has been recognized and appreciated with increasing frequency during the past few years. It is a microorganism ideally suited to the hospital environment in that it is resistant to many disinfectants and most antibiotics. Achromobacter mimics Pseudomonas aeruginosa microbiologically and clinically, but may be differentiated from the latter on the basis of flagella arrangement and antibiotic suscep-tibilities.

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 9 , Issue 2 , February 1988 , pp. 84 - 87
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Chandrasekar, PH, Arathoon, E, Levine, DP: Infections due to Achromobacter xylosoxidans. Case report and review of the literature. Infection 1986; 14:279–282.CrossRefGoogle ScholarPubMed
2.Reverdy, ME, Freney, J, Fleurette, J, et al: Nosocomial colonization and infection by Achromobacter xylosoxidans. J Clin Microbiol 1984; 19: 140–143.CrossRefGoogle ScholarPubMed
3.Gröschel, DHM, Cody, LD, Tiemann, C: Nosocomial infections with Achromobacter xylosoxidans in cancer patients. 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Boston, Massachusetts, 1979, Abstract 378.Google Scholar
4.Holmes, B, Snell, JJS, Lapage, SP: Strains of Achromobacter xylosoxidans from clinical material. J Clin Pathol 1977; 30:595–601.Google Scholar
5.Igra-Siegman, Y, Chmel, H, Cobbs, C: Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol 1980; 11:141–145.Google Scholar
6.Shigeta, S, Yasunaga, Y, Honzumi, K, et al: Cerebral ventriculitis associated with Achromobacter xylosoxidans. J Clin Pathol 1978; 31:156–161.Google Scholar
7.Namnyak, SS, Holmes, B, Fathalla, SE: Neonatal meningitis caused by Achromobacter xylosoxidans. J Clin Microbiol 1985; 22:470–471.Google Scholar
8.Pien, FD, Higa, HY: Achromobacter xylosoxidans isolates in Hawaii. J Clin Microbiol 1978; 7:239–241.Google Scholar
9.Welk, SW: Achromobacter pneumonia. West J Med 1982; 136:349–350.Google ScholarPubMed
10.Trowers, N, Stoller, F, Torres, E, et al: Achromobacter xylosoxidans implicated in infection in intensive care unit. Annual Meeting of the American Society for Microbiology, Las Vegas, Nevada, 1978, Abstract C4.Google Scholar
I I.Dworzack, DL, Murray, CM, Hodges, GR, et al: Community-acquired bacteremic Achromobacter xylosoxidans type IIIa pneumonia in a patient with idiopathic IgM deficiency. Am J Clin Pathol 1978; 70:712–717.Google Scholar
12.Newman, PE, Hider, P, Waring, GO, et al: Corneal ulcer due to Achromobacter xylosoxidans. Br J Ophthalmol 1984; 68:472–474.Google Scholar
13.Foley, JF, Gravelle, CR, Englehard, WE, et al: Achromobacter septicemia: Fatalities in prematures. Am J Dis Child 1961; 101:279–287.Google Scholar
14.Yabuuchi, E, Ohyama, A: Achromobacter xylosoxidans nov. sp. from human ear discharge. Jpn J Microbiol 1971; 15:477–481.Google Scholar
15.Olson, DA, Hoeprich, PD: Postoperative infection of an aortic prosthesis with Achromobacter xylosoxidans. West J Med 1982; 136:153–157.Google ScholarPubMed
16.Lofgren, RP, Nelson, AE, Crossley, KB: Prosthetic valve endocarditis due to Achromobacter xylosoxidans. Am Heart J 1981; 101:502.CrossRefGoogle ScholarPubMed
17.McGuckin, MB, Thorp, RJ, Koch, KM, et al: An outbreak of Achromobacter xylosoxidans related to diagnostic tracer procedures. Am J Epidemiol 1982; 115:785–793.CrossRefGoogle ScholarPubMed
18.Bergey's Manual of Determinative Bacteriology, ed 8. Baltimore, Williams & Wilkms, 1975, pp 273–275.Google Scholar
19.Chester, B, Cooper, LH: Achromobacter species (CDC Group Vd): Morphological and biochemical characterization. J Clin Microbiol 1979; 9:225–236.Google Scholar
20.Dees, SB, Moss, CW: Identification of Achromobacter species by cellular fatty acid and by production of keto acids. J Clin Microbiol 1978; 8:61–66CrossRefGoogle ScholarPubMed